BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8845360)

  • 1. Evidence for distinct DNA binding forms of the erythroid-specific transcription factor NF-E2.
    Lam LT; Bresnick EH
    Biochemistry; 1995 Dec; 34(50):16347-58. PubMed ID: 8845360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter.
    Sawado T; Igarashi K; Groudine M
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10226-31. PubMed ID: 11517325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region.
    Moi P; Chan K; Asunis I; Cao A; Kan YW
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9926-30. PubMed ID: 7937919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro.
    Armstrong JA; Emerson BM
    Mol Cell Biol; 1996 Oct; 16(10):5634-44. PubMed ID: 8816476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroid AP-1/NF-E2 elements vary in their response to NF-E2.
    Walters M; Andrews NC; Magis W; Martin DI
    Exp Hematol; 1996 Feb; 24(3):445-52. PubMed ID: 8599974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells.
    Forsberg EC; Downs KM; Bresnick EH
    Blood; 2000 Jul; 96(1):334-9. PubMed ID: 10891470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation domain of the enhancer binding protein p45NF-E2 interacts with TAFII130 and mediates long-range activation of the alpha- and beta-globin gene loci in an erythroid cell line.
    Amrolia PJ; Ramamurthy L; Saluja D; Tanese N; Jane SM; Cunningham JM
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10051-6. PubMed ID: 9294161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer.
    Kotkow KJ; Orkin SH
    Mol Cell Biol; 1995 Aug; 15(8):4640-7. PubMed ID: 7623856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple regions of p45 NF-E2 are required for beta-globin gene expression in erythroid cells.
    Bean TL; Ney PA
    Nucleic Acids Res; 1997 Jun; 25(12):2509-15. PubMed ID: 9171106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beta -globin locus control region (LCR) functions primarily by enhancing the transition from transcription initiation to elongation.
    Sawado T; Halow J; Bender MA; Groudine M
    Genes Dev; 2003 Apr; 17(8):1009-18. PubMed ID: 12672691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-DNA interactions in vivo of an erythroid-specific, human beta-globin locus enhancer.
    Reddy PM; Shen CK
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8676-80. PubMed ID: 1924329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein.
    Ney PA; Sorrentino BP; Lowrey CH; Nienhuis AW
    Nucleic Acids Res; 1990 Oct; 18(20):6011-7. PubMed ID: 2235483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of an E1A-sensitive coactivator for long-range transactivation by the beta-globin locus control region.
    Forsberg EC; Johnson K; Zaboikina TN; Mosser EA; Bresnick EH
    J Biol Chem; 1999 Sep; 274(38):26850-9. PubMed ID: 10480893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression.
    Caterina JJ; Donze D; Sun CW; Ciavatta DJ; Townes TM
    Nucleic Acids Res; 1994 Jun; 22(12):2383-91. PubMed ID: 8036168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for utilization of CREB binding protein by hypersensitive site two of the beta-globin locus control region.
    Johnson KD; Norton JE; Bresnick EH
    Nucleic Acids Res; 2002 Apr; 30(7):1522-30. PubMed ID: 11917012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control region.
    Gong QH; McDowell JC; Dean A
    Mol Cell Biol; 1996 Nov; 16(11):6055-64. PubMed ID: 8887635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer.
    Miller JL; Walsh CE; Ney PA; Samulski RJ; Nienhuis AW
    Blood; 1993 Sep; 82(6):1900-6. PubMed ID: 8400240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP-dependent protein kinase is necessary for increased NF-E2.DNA complex formation during erythroleukemia cell differentiation.
    Garingo AD; Suhasini M; Andrews NC; Pilz RB
    J Biol Chem; 1995 Apr; 270(16):9169-77. PubMed ID: 7721832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human beta-globin locus control region.
    Stamatoyannopoulos JA; Goodwin A; Joyce T; Lowrey CH
    EMBO J; 1995 Jan; 14(1):106-16. PubMed ID: 7828582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis and mapping of DNase I hypersensitivity of HS5 of the beta-globin locus control region.
    Li Q; Zhang M; Duan Z; Stamatoyannopoulos G
    Genomics; 1999 Oct; 61(2):183-93. PubMed ID: 10534403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.